Literature DB >> 22934557

Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy.

Joeke M Felderhof1, Carien L Creutzberg, Hein Putter, Remi A Nout, Judith V M G Bovée, P D Sander Dijkstra, Henk H Hartgrink, Corrie A M Marijnen.   

Abstract

BACKGROUND: To evaluate long-term local control, survival, radiation side effects and functional outcome after limb-sparing surgery followed by postoperative radiotherapy (RT) for soft tissue sarcoma (STS).
MATERIAL AND METHODS: Between 1995 and 2010, 118 patients with STS of an extremity were treated with limb-sparing surgery and postoperative RT. Follow-up was complete for all patients. Acute and late radiation related toxicities were scored using CTCAE v4.0.
RESULTS: Median follow-up was 93 months. RT dose was 60 Gy in 92.4% of the patients; 5.1% received 66 Gy; 2.5% 50-56 Gy. Actuarial local recurrence rates at five and 10 years were 9% and 12%. Five- and 10-year overall survival rates were 69% and 51%. Acute radiation toxicities occurred in 91% of the patients; 19% were grade 3, 2% grade 4. Late radiation toxicities were reported in 71% of the patients: 50% grade 1, 18% grade 2, and 3% grade 3. Limb and joint function after treatment were good, 19% having mild limitation of motion, 1.5% moderate, and 2.5% severe limitations.
CONCLUSION: Limb-sparing surgery with 60 Gy postoperative radiotherapy for patients with STS provides excellent local control and high survival rates with acceptable toxicity and functional outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22934557     DOI: 10.3109/0284186X.2012.709947

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

Review 1.  Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy.

Authors:  Mohamed H Abouarab; Iman L Salem; Magdy M Degheidy; Dominic Henn; Christoph Hirche; Ahmad Eweida; Matthias Uhl; Ulrich Kneser; Thomas Kremer
Journal:  Int Wound J       Date:  2017-12-05       Impact factor: 3.315

Review 2.  Soft tissue sarcoma and radiation therapy advances, impact on toxicity.

Authors:  Nancy El-Bared; Philip Wong; Dian Wang
Journal:  Curr Treat Options Oncol       Date:  2015-05

Review 3.  [Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?]

Authors:  I-M Noebauer-Huhmann; T Grieser
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

Review 4.  Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy.

Authors:  Nisreen S Ezuddin; Juan Pretell-Mazzini; Raphael L Yechieli; Darcy A Kerr; Breelyn A Wilky; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2018-05-21       Impact factor: 2.199

5.  Limb-sparing surgery with latissimus dorsi flap reconstruction in extremity soft tissue sarcoma: Case series.

Authors:  Erwin Danil Yulian; Hana Qonita; Evelina Kodrat; Kevin Varian Marcevianto
Journal:  Int J Surg Case Rep       Date:  2022-06-24

6.  Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?

Authors:  Patrick England; Zachery Hong; Lee Rhea; Angela Hirbe; Douglas McDonald; Cara Cipriano
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

Review 7.  Intraoperative radiation therapy (IORT) in soft-tissue sarcoma.

Authors:  Falk Roeder; Robert Krempien
Journal:  Radiat Oncol       Date:  2017-01-19       Impact factor: 3.481

8.  Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.

Authors:  Falk Roeder; Burkhard Lehner; Thomas Schmitt; Bernd Kasper; Gerlinde Egerer; Oliver Sedlaczek; Carsten Grüllich; Gunhild Mechtersheimer; Patrick Wuchter; Frank W Hensley; Peter E Huber; Juergen Debus; Marc Bischof
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

9.  Hyperbaric oxygen therapy for radiation-induced tissue injury following sarcoma treatment: A retrospective analysis of a Dutch cohort.

Authors:  Jasmijn D Generaal; Corine A Lansdorp; Onno Boonstra; Barbara L van Leeuwen; Hubertus A M Vanhauten; Marc G Stevenson; Lukas B Been
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.